Across TCGA pan-cancer cohorts, RNA5SP330 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNA5SP330’s most consistent transcriptional readouts.
The strongest signal is observed in stomach adenocarcinoma (STAD), where RNA5SP330 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNA5SP330 is over-expressed in tumor.
STAD and THCA are the cancer types where RNA5SP330 tumor–normal differential expression is most reproducible.